Trial Profile
Significance of the FSH receptor polymorphism p.N680S for the efficacy of FSH therapy of idiopathic male infertility: a pharmacogenetic approach.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Male infertility
- Focus Pharmacogenomic; Therapeutic Use
- 14 Nov 2015 Status changed from active, no longer recruiting to completed as per European Clinical Trials Database record.
- 22 Mar 2012 New trial record